Inc. Abbvie serves as Executive at REATA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Inc. Abbvie has executed 2 insider transactions totaling $10.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 28, 2017 involved selling 450,000 shares valued at $10.1M.
Inc. Abbvie currently holds 1,190,473 shares of REATA PHARMACEUTICALS INC (RETA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Abbvie has been a net seller of RETA stock. They have purchased $0 and sold $10.1M worth of shares.
Inc. Abbvie's most recent insider trade was on Mar 28, 2017, when they sold 450,000 shares at $22.50 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |